US HB5801 | 2023-2024 | 118th Congress


Spectrum: Bipartisan Bill
Status: Introduced on September 28 2023 - 25% progression
Action: 2023-09-29 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]


To ensure that expenses relating to the acquisition or use of devices for use in the detection of fentanyl, xylazine, and other emerging adulterant substances, including test strips, are allowable expenses under certain grant programs.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.


Preventing Overdoses with Test Strips Act



2023-09-29HouseReferred to the Subcommittee on Health.
2023-09-28HouseReferred to the House Committee on Energy and Commerce.
2023-09-28HouseIntroduced in House

Same As/Similar To

SB2976 (Related) 2023-09-28 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.


US Congress State Sources

Bill Comments